Literature DB >> 7246487

Neonatal necrotizing enterocolitis: a nine-year experience. II. Outcome assessment.

R M Kliegman, A A Fanaroff.   

Abstract

Mortality was assessed in a nine-year experience with 123 patients with necrotizing enterocolitis. Overall mortality was 45%. Despite intestinal perforation among surgically treated patients, there was no difference in mortality between surgically or medically treated patients(46% vs 54%). Patients with only hematochezia or abdominal distention has a lower mortality than those who appeared "septic" (35% vs 68%). Similarly, those with bacteremia and disseminated intravascular coagulation had high mortality as well as those in whom peritonitis with ascites developed. When the entire patient population is considered, prior therapy with ascites developed. When the entire patient population is considered, prior therapy with systemic antibiotics or concomitant therapy with oral aminoglycosides had no effect on severity of the disease, occurrence of intestinal perforation, or mortality.

Entities:  

Mesh:

Year:  1981        PMID: 7246487     DOI: 10.1001/archpedi.1981.02130310014006

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  16 in total

1.  Laparotomy or drain for perforated necrotizing enterocolitis: who gets what and why?

Authors:  K S Azarow; S H Ein; B Shandling; D Wesson; R Superina; R M Filler
Journal:  Pediatr Surg Int       Date:  1997-02       Impact factor: 1.827

2.  Surveillance of necrotising enterocolitis, 1981-2.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1983-09-17

3.  Apical sodium-dependent bile acid transporter upregulation is associated with necrotizing enterocolitis.

Authors:  Melissa D Halpern; Jörn-Hendrik Weitkamp; Sarah K Mount Patrick; Holly J Dobrenen; Ludmila Khailova; Hernan Correa; Bohuslav Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-07-08       Impact factor: 4.052

4.  Outcome of neonatal necrotising enterocolitis: results of the BAPM/CDSC surveillance study, 1981-84.

Authors:  S R Palmer; A Biffin; H R Gamsu
Journal:  Arch Dis Child       Date:  1989-03       Impact factor: 3.791

Review 5.  Does abnormal bile acid metabolism contribute to NEC?

Authors:  Melissa D Halpern; Bohuslav Dvorak
Journal:  Semin Perinatol       Date:  2008-04       Impact factor: 3.300

6.  Decreased development of necrotizing enterocolitis in IL-18-deficient mice.

Authors:  Melissa D Halpern; Ludmila Khailova; Dania Molla-Hosseini; Kelly Arganbright; Charity Reynolds; Masako Yajima; Junji Hoshiba; Bohuslav Dvorak
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-10-18       Impact factor: 4.052

7.  Necrotizing enterocolitis mortality in the United States, 1979-85.

Authors:  R C Holman; J K Stehr-Green; M T Zelasky
Journal:  Am J Public Health       Date:  1989-08       Impact factor: 9.308

Review 8.  Milk epidermal growth factor and gut protection.

Authors:  Bohuslav Dvorak
Journal:  J Pediatr       Date:  2010-02       Impact factor: 4.406

Review 9.  Necrotizing enterocolitis.

Authors:  A Kulkarni; R Vigneswaran
Journal:  Indian J Pediatr       Date:  2001-09       Impact factor: 1.967

10.  Transgenic Soybean Production of Bioactive Human Epidermal Growth Factor (EGF).

Authors:  Yonghua He; Monica A Schmidt; Christopher Erwin; Jun Guo; Raphael Sun; Ken Pendarvis; Brad W Warner; Eliot M Herman
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.